Taiwan Bio-medical 'National Team' Enters Japan, Partners with iPark to Expand in Asia-Pacific
NQ Score
0/100
N1 Content Completeness
5
AI Summary (NQ-processed)
A delegation of 16 Taiwanese bio-medical companies led by the MOEA participated in CPHI Japan. ITRI signed an MOU with Shonan Health Innovation Park (iPark Institute) to establish a complementary mechanism for R&D, clinical trials, and manufacturing, facilitating Taiwan's entry into the Japanese and Asia-Pacific markets.